Positive Patient Stories™

Paratek Pharmaceuticals News

Webcast ImageWebcast
Fourth Quarter and Fiscal Year 2018 Earnings Call  (Replay)
02/27/19 at 4:30 p.m. ET
Fourth Quarter and Fiscal Year 2018 Earnings Call
Wednesday, February 27, 2019 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
8th Annual SVB Leerink Global Healthcare Conference (Replay)
02/28/19 at 1:00 p.m. ET
8th Annual SVB Leerink Global Healthcare Conference
Thursday, February 28, 2019 1:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Paratek Pharmaceuticals Presentation at the Cowen and Company 39th Annual Health Care Conference (Replay)
03/13/19 at 10:00 a.m. ET
Paratek Pharmaceuticals Presentation at the Cowen and Company 39th Annual Health Care Conference
Wednesday, March 13, 2019 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
DateTitle  
12/13/16Paratek Advances Timing of Top-Line Data for Phase 3 Community Acquired Bacterial Pneumonia Study to the Second Quarter of 2017 
11/02/16Paratek Pharmaceuticals, Inc. Reports Third Quarter 2016 Financial Results and Provides Clinical Updates 
10/26/16Paratek Pharmaceuticals, Inc. to Host R&D Day on November 17, 2016 
10/24/16Paratek Pharmaceuticals to Report Third Quarter 2016 Financial Results and Provide Update on Clinical Progress on November 2, 2016 
10/11/16Paratek, U.S. Department of Defense Enter Research Agreement to Study Omadacycline Against Biodefense Pathogens 
10/04/16Paratek to Ring Nasdaq Closing Bell Recognizing 20th Anniversary 
09/01/16Paratek Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences 
08/15/16Paratek Initiates Phase 3 Study of Oral-only Omadacycline in ABSSSI 
08/04/16Paratek Pharmaceuticals, Inc. Reports Second Quarter 2016 Financial and Operating Results 
07/22/16Paratek Pharmaceuticals to Report Second Quarter 2016 Financial Results on August 4, 2016 
06/27/16Paratek Announces Closing of Common Stock Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares 
06/22/16Paratek Announces Pricing of Public Offering of 4,250,000 Shares of Common Stock 
06/20/16Paratek Announces Proposed Public Offering of Common Stock 
06/20/16Paratek Accelerates Timing for Projected Reporting of Top-Line Data for Omadacycline Phase 1b Urinary Tract Infection Study 
06/16/16Paratek Announces that Omadacycline Met All Primary and Secondary Efficacy Outcomes Designated by FDA and EMA in a Phase 3 Study in Acute Bacterial Skin Infections; Omadacycline was Generally Safe and Well-Tolerated 
06/13/16Paratek to Present Omadacycline Microbiologic, Pharmacokinetic and Clinical Data at ASM Microbe 2016 
06/01/16Paratek Pharmaceuticals, Inc. Announces Participation in JMP Securities Life Sciences Conference 
05/10/16Paratek Receives FDA Affirmation for Design of Proposed Omadacycline Oral-Only Skin Infection Phase 3 Study: Opportunity to Accelerate Access to Broader Oral-Only Markets 
05/02/16Paratek Pharmaceuticals, Inc. Reports First Quarter 2016 Financial and Operating Results 
05/02/16Paratek Initiates Phase 1b Study of Omadacycline in Urinary Tract Infection 
04/25/16Paratek Pharmaceuticals to Report First Quarter 2016 Financial Results on May 3, 2016 
04/11/16Paratek Presents Data from Omadacycline Clinical Development Program at ECCMID 
04/11/16Paratek Presents Pre-Clinical Data on the Effects of Omadacycline on Clostridium Difficile 
04/04/16Paratek Announces Completion of Enrollment for Omadacycline Phase 3 Skin Study 
03/29/16Paratek to Present Clinical Findings at ECCMID 2016 
03/03/16Kris Peterson to Join Paratek Board of Directors 
02/23/16Paratek Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2015 Financial and Operating Results 
02/16/16Paratek Pharmaceuticals to Report Fourth Quarter 2015 Financial Results on February 23, 2016 
02/16/16Paratek Pharmaceuticals, Inc. to Present at Two Upcoming Investor Conferences 
01/28/16Paratek Pharmaceuticals, Inc. Announces Participation in LEERINK Partners 5th Annual Global Healthcare Conference 
01/06/16Paratek Accelerates Timing for Projected Reporting of Top-Line Data for Omadacycline Phase 3 Skin Trial 

Talk with the Paratek Team

Send us an inquiry by submitting a form directly on the site or give us a call.